TABLE 4.

Drug-related adverse events reported for ≥1% of patients in either group and associated rate of drug discontinuation

Adverse event	Linezolid-treated patients (n = 2,046)				Comparator-treated patients (n = 2,001)
	Drug-related adverse events		Rate of drug discontinuation		Drug-related adverse events		Rate of drug discontinuation
	No.	%a	No.	%	No.	%a	No.	%
Patients with at least one	444	21.7	50	2.4	314	15.7	38	1.9
Diarrhea	89	4.3	6	0.3	65	3.2	4	0.2
Nausea	69	3.4	11	0.5	46	2.3	3	0.1
Headache	44	2.2	8	0.4	27	1.3	1	<0.1
Taste perversionb	24	1.2	0	0	14	0.7	1	<0.1
Moniliasis, vaginal	24	1.2	0	0	13	0.6	0	0
Vomiting	23	1.1	6	0.3	8	0.4	3	0.1
Liver function test abnormality	21	1.0	3	0.1	7	0.3	1	<0.1

^aPercentages are based on the number of patients reporting an adverse event. Patients are counted once per adverse event.

^bBitter taste reported.